TIM-3 expression in human osteosarcoma: Correlation with the expression of epithelial-mesenchymal transition-specific biomarkers

TIMgenes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity

(2015) Gordon J. Freeman et al.   IMMUNOLOGICAL REVIEWS

The characteristic expression of B7-associated proteins in Langerhans cell sarcoma

(2012) Hong Li et al.   ACTA HISTOCHEMICA

Ectopic Expression of TIM-3 in Lung Cancers

(2012) Xuewei Zhuang et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Role of Cripto-1 during Epithelial-to-Mesenchymal Transition in Development and Cancer

(2012) Maria C. Rangel et al.   AMERICAN JOURNAL OF PATHOLOGY

Combined blockade of TIM-3 and TIM-4 augments cancer vaccine efficacy against established melanomas

(2012) Muhammad Baghdadi et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Microenvironmental Regulation of Epithelial-Mesenchymal Transitions in Cancer

(2012) D. Gao et al.   CANCER RESEARCH

Primary osteosarcoma arising from subcutaneous tissue: 5-year follow-up

(2012) Aysegul Sarsilmaz et al.   CLINICAL IMAGING

Epithelial-mesenchymal transitions: insights from development

(2012) J. Lim et al.   DEVELOPMENT

Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma

(2012) Hang Li et al.   HEPATOLOGY

The US postmarketing surveillance study of adult osteosarcoma and teriparatide: Study design and findings from the first 7 years

(2012) Elizabeth B Andrews et al.   JOURNAL OF BONE AND MINERAL RESEARCH

IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma

(2012) Zhi-Zhang Yang et al.   JOURNAL OF CLINICAL INVESTIGATION

Cancer Vaccines Targeting the Epithelial-Mesenchymal Transition: Tissue Distribution of Brachyury and Other Drivers of the Mesenchymal-Like Phenotype of Carcinomas

(2012) Duane H. Hamilton et al.   SEMINARS IN ONCOLOGY

Epigenetic reprogramming and post-transcriptional regulation during the epithelial–mesenchymal transition

(2012) Chung-Yin Wu et al.   TRENDS IN GENETICS

Molecular pathology and its diagnostic use in bone tumors

(2012) Karoly Szuhai et al.   Cancer Genetics

Immunotherapy of prostate cancer: should we be targeting stem cells and EMT?

(2011) Naomi L. Dunning et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

The epidemiology of bone cancer in 0 - 39 year olds in northern England, 1981 - 2002

(2010) Rachel Eyre et al.   BMC CANCER

Silencing of Autocrine Motility Factor Induces Mesenchymal-to-Epithelial Transition and Suppression of Osteosarcoma Pulmonary Metastasis

(2010) Y. Niinaka et al.   CANCER RESEARCH

The phosphatidylserine receptors, T cell immunoglobulin mucin proteins 3 and 4, are markers of histiocytic sarcoma and other histiocytic and dendritic cell neoplasms

(2010) David M. Dorfman et al.   HUMAN PATHOLOGY

Antagonism of TIM-1 blocks the development of disease in a humanized mouse model of allergic asthma

(2010) Sanchaita Sriwal Sonar et al.   JOURNAL OF CLINICAL INVESTIGATION

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

(2010) Kaori Sakuishi et al.   JOURNAL OF EXPERIMENTAL MEDICINE

T and B cell hyperactivity and autoimmunity associated with niche-specific defects in apoptotic body clearance in TIM-4-deficient mice

(2010) R. Rodriguez-Manzanet et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer

(2009) David J. McConkey et al.   CANCER AND METASTASIS REVIEWS